Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Total article views   Abstract views HTML views PDF downloads Totals
9,536 Dovepress* 7,903 497+ 1,547 8,400
PubMed Central* 2 1,134 597 1,136
Totals 7,905 1,631 2,144 9,536
*Since 14 September 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar